ALMKT:EPA
Mauna Kea Technologies SA
€ 0.092
0.00%
(0.00) Siku 1
13 Nov, 17:35:01 GMT +1 · EUR
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya ALMKT...
Fungua
€ 0.09
Juu
€ 0.10
Chini
€ 0.09
Mtaji wa soko
18.14M
Wastani wa kiasi cha mauzo
elfu 541.14
Kiasi cha mauzo ya hisa
elfu 75.16
Uwiano wa bei ya hisa na mapato kwa kila hisa
0.79
Juu kwa wiki 52
€ 0.23
Chini kwa wiki 52
€ 0.07
EPS
€ 0.12
Hisa za wawekezaji
195.26M
Idadi ya wafanyakazi
56
Fungua
€ 0.09
Juu
€ 0.10
Chini
€ 0.09
Mtaji wa soko
18.14M
Wastani wa kiasi cha mauzo
elfu 541.14
Kiasi cha mauzo ya hisa
elfu 75.16
Uwiano wa bei ya hisa na mapato kwa kila hisa
0.79
Juu kwa wiki 52
€ 0.23
Chini kwa wiki 52
€ 0.07
EPS
€ 0.12
Hisa za wawekezaji
195.26M
Idadi ya wafanyakazi
56
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Foreign Policy Journal
·
dakika 33 zilizopita
AST SpaceMobile (NASDAQ: ASTS) Carries A $10.4 Billion Valuation While Its Biggest New Contract Is Worth Just 1% Of That
The Motley Fool
·
saa 1 iliyopita
Prediction: This Small-Cap Value ETF Will Beat the S&P 500 Over the Next 10 Years
Seeking Alpha
·
saa 1 iliyopita
Cerebras: Timely Buying Opportunity After The Collapse (Rating Upgrade) (NASDAQ:CBRS)
CNBC
·
saa 22 zilizopita
Is a bottom in for the Nasdaq-100? Charts to watch
Wasifu
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Kuhusu Mauna Kea Technologies SA
Afisa Mkuu Mtendaji (CEO)Sacha Loiseau
Wafanyakazi56
Lilianzishwa2000
Makao makuu-
SektaHealth Care
Sekta-
Tovutimaunakeatech.com